92 related articles for article (PubMed ID: 25403326)
1. Serum HLA-G levels in women with polycystic ovary syndrome.
Oztekin O; Fenkci SM; Fenkci V; Enli Y; Cabus U
Gynecol Endocrinol; 2015 Mar; 31(3):243-6. PubMed ID: 25403326
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
[TBL] [Abstract][Full Text] [Related]
3. Is interleukin-18 associated with polycystic ovary syndrome?
Yang Y; Qiao J; Li R; Li MZ
Reprod Biol Endocrinol; 2011 Jan; 9():7. PubMed ID: 21244650
[TBL] [Abstract][Full Text] [Related]
4. Obesity contributes to telomere shortening in polycystic ovary syndrome.
Kogure GS; Verruma CG; Santana BA; Calado RT; Ferriani RA; Furtado CLM; Dos Reis RM
Reprod Sci; 2024 Jun; 31(6):1601-1609. PubMed ID: 38393627
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
Pustotina O; Myers SH; Unfer V; Rasulova I
Gynecol Obstet Invest; 2024; 89(2):131-139. PubMed ID: 38295772
[TBL] [Abstract][Full Text] [Related]
6. The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome.
Ting Z; Xinghua T; Xiao X; Lingchuan L; Xiaomei W; Tao Y
Gynecol Endocrinol; 2024 Dec; 40(1):2352136. PubMed ID: 38733359
[TBL] [Abstract][Full Text] [Related]
7. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome.
Fruzzetti F; Fidecicchi T; Benelli E; Baldari F; Tonacchera M
J Endocrinol Invest; 2024 Apr; 47(4):927-936. PubMed ID: 37907709
[TBL] [Abstract][Full Text] [Related]
8. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.
Ebrahimi-Mamaghani M; Saghafi-Asl M; Pirouzpanah S; Aliasgharzadeh A; Aliashrafi S; Rezayi N; Mehrzad-Sadaghiani M
J Health Popul Nutr; 2015 Mar; 33(1):157-67. PubMed ID: 25995732
[TBL] [Abstract][Full Text] [Related]
9. Effects of quercetin on polycystic ovary syndrome in animal models: a systematic review and meta-analysis.
Su P; Chen C; Pang L; Wu K; Sun Y
Reprod Biol Endocrinol; 2024 Apr; 22(1):46. PubMed ID: 38637876
[TBL] [Abstract][Full Text] [Related]
10. Association of Macronutrients Composition, Physical Activity and Serum Androgen Concentration in Young Women with Polycystic Ovary Syndrome.
Mizgier M; Watrowski R; Opydo-Szymaczek J; Jodłowska-Siewert E; Lombardi G; Kędzia W; Jarząbek-Bielecka G
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010948
[TBL] [Abstract][Full Text] [Related]
11. Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism.
Suresh S; Vijayakumar T
Indian J Clin Biochem; 2015 Jul; 30(3):345-50. PubMed ID: 26089623
[TBL] [Abstract][Full Text] [Related]
12. Endocrinological and Metabolic Heterogeneity Is Low in Japanese Women With Polycystic Ovary Syndrome.
Baba T; Endo T; Mariya T; Kuno Y; Honnma H; Kanaya M; Saito T
J Obstet Gynaecol Can; 2024 Jan; 46(1):102217. PubMed ID: 37709141
[TBL] [Abstract][Full Text] [Related]
13. The effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study.
Shi D; Du J; Kang H; Feng L; Liu F
Gynecol Endocrinol; 2024 Dec; 40(1):2358219. PubMed ID: 38835150
[TBL] [Abstract][Full Text] [Related]
14. Determinants of Bone Mineral Density in Iranian Women with Polycystic Ovary Syndrome.
Karimi F; Mardani P
Int J Endocrinol Metab; 2023 Oct; 21(4):e137594. PubMed ID: 38666045
[TBL] [Abstract][Full Text] [Related]
15. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome.
Qu X; Donnelly R
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33139661
[TBL] [Abstract][Full Text] [Related]
16. The impact of sleeve gastrectomy on polycystic ovarian syndrome: a single-center 1-year cohort study.
Alamdari NM; Sadegh GHM; Farsi Y; Besharat S; Hajimirzaie SH; Abbasi M
Ir J Med Sci; 2024 Apr; 193(2):721-724. PubMed ID: 37574528
[TBL] [Abstract][Full Text] [Related]
17. Astragalus polysaccharide alleviates polycystic ovary syndrome by reducing insulin resistance and oxidative stress and increasing the diversity of gut microbiota.
Li R; Hu R; Huang Y; Li D; Ma X; Yang Y
Endocrine; 2024 Mar; 83(3):783-797. PubMed ID: 37824046
[TBL] [Abstract][Full Text] [Related]
18. Endocrinal and autoimmune linkage: Evidences from a controlled study of subjects with polycystic ovarian syndrome.
Arora S; Sinha K; Kolte S; Mandal A
J Hum Reprod Sci; 2016; 9(1):18-22. PubMed ID: 27110073
[TBL] [Abstract][Full Text] [Related]
19. Association between serum levels of calcium, magnesium, iron and copper and insulin resistance in women with full blown and not-full blown phenotypes of polycystic ovary syndrome.
Skrypnik K; Pluta D; Wojtowicz M; Rhaiem TB; Suliburska J
Ginekol Pol; 2024 May; ():. PubMed ID: 38717226
[TBL] [Abstract][Full Text] [Related]
20. Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy.
Singh B; Panda S; Nanda R; Pati S; Mangaraj M; Sahu PK; Mohapatra PC
Indian J Clin Biochem; 2010 Oct; 25(4):367-70. PubMed ID: 21966106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
